supp.fit

Valerian: study protocols

23 study groups say how much Valerian participants took a day. These are the doses the studies gave. They are not a recommendation.

Valerian: what the research found →

Dose per serving from products

361 products in our catalogue print how much Valerian a serving holds.

Most common: 250 mg to 500 mg, 18% of 361 products.

Dose per servingProducts
2.5 mg or less
5
2.5 mg to 5 mg
14
5 mg to 10 mg
4
10 mg to 25 mg
26
25 mg to 50 mg
61
50 mg to 100 mg
46
100 mg to 250 mg
64
250 mg to 500 mg
65
500 mg to 1 g
49
1 g to 2.5 g
27

Dose per serving from research

22 study groups in 21 studies say how much Valerian participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 500 mg to 1 g, 36% of 22 study groups.

Daily doseStudy groups
100 mg or less
1
100 mg to 250 mg
3
250 mg to 500 mg
6
500 mg to 1 g
8
1 g to 2.5 g
4

Commonly used together

8 of 23 study groups took Valerian with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Hops
4

23 study groups

Study
Effects of valerian on the severity and systemic manifestations of dysmenorrhea
2011 · valerian · Students with dysmenorrhea
765 mg—49
Valeriana officinalis Root Extract Modulates Cortical Excitatory Circuits in Humans
2017 · Valeriana officinalis extract (VE) · 15 healthy volunteers; age and sex not specified
900 mg1 day15
The effect of valerian extract on sleep polygraphy in poor sleepers: a pilot study
1994 · valerian group · elderly poor sleepers
1.22 g7 days8
[Efficacy and tolerability of Baldrian versus oxazepam in non-organic and non-psychiatric insomniacs: a randomised, double-blind, clinical, comparative study]
2000 · index group · Adults aged 18–70 years with non-organic and non-psychiatric insomnia
600 mg4 weeks—
Efficacy and tolerability of valerian extract LI 156 compared with oxazepam in the treatment of non-organic insomnia--a randomized, double-blind, comparative clinical study
2002 · Valerian extract LI 156 group · Adults aged 18 to 73 years with non-organic insomnia
600 mg6 weeks—
Effect of valerian on sleep quality in postmenopausal women: a randomized placebo-controlled clinical trial
2011 · valerian extract group · Postmenopausal women aged 50–60 years experiencing insomnia
1.06 g4 weeks—
Extract of valerian root (Valeriana officinalis L.) vs. placebo in treatment of obsessive-compulsive disorder: a randomized double-blind study
2011 · extract group · Adults with obsessive-compulsive disorder (OCD)
765 mg8 weeks—
Can Valeriana officinalis root extract prevent early postoperative cognitive dysfunction after CABG surgery? A randomized, double-blind, placebo-controlled trial
2015 · valerian group · Adults aged 30–70 scheduled for elective on-pump CABG surgery
1.06 g8 weeks—
The effect of Valerian on the severity and frequency of hot flashes: A triple-blind randomized clinical trial
2018 · Valerian · Postmenopausal women aged 45–55 with hot flashes
1.06 g60 days—
The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5)
2011 · valerian · Adults with cancer receiving cancer therapy who reported difficulty sleeping
450 mg8 weeks62
Effect of valerian on cognitive disorders and electroencephalography in hemodialysis patients: a randomized, cross over, double-blind clinical trial
2018 · Valerian treatment phase · Adults over 18 years with end-stage renal disease receiving hemodialysis
530 mg30 days39
Effect of Valerian in Preventing Neuropsychiatric Adverse Effects of Efavirenz in HIV-Positive Patients: A Pilot Randomized, Placebo-Controlled Clinical Trial
2017 · valerian group · HIV-positive patients receiving efavirenz
530 mg4 weeks25
Standardized Extract of Valeriana officinalis Improves Overall Sleep Quality in Human Subjects with Sleep Complaints: A Randomized, Double-Blind, Placebo-Controlled, Clinical Study
2024 · VE group · Healthy male and female adults aged 18–50 with mild insomnia symptoms and no comorbidities
200 mg8 weeks40
Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial
2005 · valerian-hops combination · Adults with mild insomnia; mean age 44.3 years; 110 women and 74 men across the study
187 mg4 weeks59
Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: a randomized controlled trial
2013 · NSF-3 group · Adults of either sex diagnosed with primary insomnia
300 mg2 weeks39
Sleep improving effects of a single dose administration of a valerian/hops fluid extract - a double blind, randomized, placebo-controlled sleep-EEG study in a parallel design using electrohypnograms
2008 · verum · Poor sleepers identified by the validated sleep questionnaire SF-B; age and sex not reported
2 mL1 day20
Effects of a Valerian-Hops Extract Combination (Ze 91019) on Sleep Duration and Daytime Cognitive and Psychological Parameters in Occasional Insomnia: A Randomized Controlled Feasibility Trial
2025 · Ze 91019 · Healthy men and women aged 18–65 with occasional sleep problems and subjective cognitive difficulties, without diagnosed insomnia
500 mg3 weeks18
The chronic effects of a combination of herbal extracts (Euphytose(®)) on psychological mood state and response to a laboratory stressor: A randomised, placebo-controlled, double blind study in healthy humans
2022 · MHEP (Euphytose) · Healthy adults aged 19–58 years, 19 female; no relevant medical condition or disease
150 mg2 weeks27
Optimisation and Validation of a Nutritional Intervention to Enhance Sleep Quality and Quantity
2020 · optimal drink · Healthy adult males; validation cohort aged 25.1 ± 6.2 years, with no reported sleep disorder
600 mg1 day18
Optimisation and Validation of a Nutritional Intervention to Enhance Sleep Quality and Quantity
2020 · least optimal drink · Healthy adult males; validation cohort aged 25.1 ± 6.2 years, with no reported sleep disorder
500 mg1 day18
In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes
2005 · valerian supplementation · 12 healthy young adults, mean age 24 ± 3 years; 6 female
375 mg4 weeks12
Valerian extract alters functional brain connectivity: A randomized double-blind placebo-controlled trial
2019 · VRE group · Nonclinical volunteers experiencing psychological stress; age and sex not specified
300 mg4 weeks—
Early effect of NEURAPAS® balance on current source density (CSD) of human EEG
2011 · NEURAPAS® balance (verum) · Healthy adult volunteers, 8 men and 8 women, mean ages about 47–49 years
28 mg1 day16